Title:
ＪＡＫ１阻害剤のための徐放性剤形
Document Type and Number:
Japanese Patent JP7126643
Kind Code:
B2
Abstract:
This invention relates to sustained release dosage forms comprising {1-{1-[3-fluoro-2-(trifluoromethyl)isonicotinoyl]piperidin-4-yl}-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile, or a pharmaceutically acceptable salt thereof, and doses and methods related thereto.
Inventors:
Krishna Swami Yereswaram
Babnish Parik
Dirip Pee Modi
Tulpti Shate
Babnish Parik
Dirip Pee Modi
Tulpti Shate
Application Number:
JP2021077724A
Publication Date:
August 29, 2022
Filing Date:
April 30, 2021
Export Citation:
Assignee:
INCYTE HOLDINGS CORPORATION
International Classes:
A61K31/519; A61K9/20; A61K47/12; A61K47/26; A61K47/38; A61P1/04; A61P3/10; A61P5/14; A61P7/00; A61P9/00; A61P13/12; A61P17/00; A61P17/04; A61P17/06; A61P19/02; A61P19/08; A61P19/10; A61P21/04; A61P25/00; A61P29/00; A61P35/00; A61P35/02; A61P37/06; A61P37/08; A61P43/00
Domestic Patent References:
| JP2013520436A | ||||
| JP2013522214A | ||||
| JP2011514909A | ||||
| JP2013514356A |
Attorney, Agent or Firm:
Michiko Matsutani
Yasushi Ochiai
Yasushi Ochiai
Previous Patent: Antibacterial coating agent, printed matter using it
Next Patent: electrical stimulator
Next Patent: electrical stimulator